ZhuZhou QianJin Pharmaceutical Unit Gets China Nod for Premature Ejaculation Tablets; Shares Fall 3%

MT NewswiresDec 13 12:24

Express News | Zhuzhou Qianjin Pharmaceutical: Subsidiary obtained the pharmaceutical registration certificate for Dapoxetine Hydrochloride tablets.

BreakingsDec 12 17:18

Express News | Zhuzhou Qianjin Pharmaceutical: The subsidiary Qianjin Xiangjiang Pharmaceutical has received the Pharmaceutical registration certificate for Dapoxetine hydrochloride tablets.

BreakingsDec 12 17:18

Zhuzhou Qianjin Pharmaceutical (600479.SH): Currently, there are no drugs for the auxiliary treatment of AIDS.

Gelonghui reported on December 10 that Zhuzhou Qianjin Pharmaceutical (600479.SH) stated on the investor interaction platform that the company currently has no drugs for the auxiliary treatment of AIDS.

Gelonghui FinanceDec 10 17:58

Zhuzhou Qianjin Pharmaceutical (600479.SH): Recently, the sales of sanitary products have shown a growth trend.

Gelonghui reported on November 27 that zhuzhou qianjin pharmaceutical (600479.SH) indicated on the investor interaction platform that the sales proportion of sanitary products in the third quarter of 2024 is 3.48%, and recently, sales of sanitary products have shown an upward trend.

Gelonghui FinanceNov 27 16:15

Zhuzhou Qianjin Pharmaceutical (600479): Short-term profit affected by traditional Chinese medicine prices, strengthening research and development investment to promote the implementation of the global strategy.

In the first three quarters of 2024, the company achieved revenue of 2.715 billion yuan, a year-on-year decrease of 2.31%; net income attributable to owners of the parent company was 0.168 billion yuan, a year-on-year decrease of 14.64%; non-net income attributable to owners of the parent company was 0.162 billion yuan, a year-on-year decrease of 14.

china merchantsNov 25 00:00